We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquila En Regulatory News (AEET)

Share Price Information for Aquila En (AEET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.75
Bid: 61.00
Ask: 64.50
Change: -0.50 (-0.79%)
Spread: 3.50 (5.738%)
Open: 64.50
High: 64.50
Low: 62.75
Prev. Close: 63.25
AEET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unaudited NAV and Return of Capital

6 Mar 2024 14:45

RNS Number : 8719F
Aquila Energy Efficiency Trust PLC
06 March 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, AUSTRALIA, NEW ZEALAND OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

6 March 2024

Aquila Energy Efficiency Trust PLC

(the "Company")

Unaudited NAV and Return of Capital

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

The Company today announces its unaudited net asset value ("NAV") as at 31 December 2023, on a cum-income basis, was £94.28 million (£93.54 million as at 30 June 2023) or 94.28 pence per ordinary share (93.54 pence as at 30 June 2023).

The NAV as at 31 December 2023 was as follows:

Summary

£m

Investments

65.48

Cash and cash equivalents

29.08

Other net current assets

(0.28)

NAV

94.28

Non GBP investments are valued in local currency and translated at ?1.1535:£1. For cash in Euro accounts, converted at ?1.1535:£1.

Cash and cash equivalents

The cash and cash equivalents figure of £29.08 million noted above includes £2.5 million of cash held as collateral for the Company's existing currency hedges held in line with its strategy.

Managed run-off update

Since the date of the continuation vote in February 2023, no new commitments have been added and the investment adviser has, where possible, renegotiated some of the existing commitments, so as to reduce the amount of further investment required by the Company. As a consequence, at 31 December 2023, the Company and its immediate investment holding entities had contractual legal obligations in relation to existing investments (the "Unfunded Commitments") equivalent to approximately £5.58 million (translating Euro obligations at ?1.1535:£1 and including an allowance for external transaction costs). Since 31 December 2023, £0.51 million of those Unfunded Commitments have been added to existing investments.

Following the Company's AGM held in June 2023, the Company's portfolio is being managed in accordance with the Managed Run-Off Resolution as approved by shareholders at that AGM.

Relationships with ESCOs have, in some cases, been affected by the Company being placed into a managed run-off and an appropriate level of provision has been made in the unaudited NAV to reflect some potential bad debts. The Board is working closely with the investment adviser to limit, where possible, erosion of value because of the run-off status of the Company. Further details will be provided in the Annual Report and Accounts to 31 December 2023 which are due to be published in April.

Process update

On 16 August 2023, the Company announced a process to market-test a portfolio sale which was conducted by Stifel Nicolaus Europe Limited ("Stifel"). An extensive number of UK and international investors were approached through this process which completed in early February. Due to the large number of Company investments across multiple geographies, the sale preparation process and the due diligence processes carried out by bidders took longer than was originally planned.

Despite interest from a number of parties who entered into the sale process, the Board has not received a definitive proposal which it believes, at this time, could deliver greater value to shareholders than the Managed Run-Off. Given the complexity and the very long dated nature of some of the investments, the Board will continue to seek and evaluate any other strategic proposals which would deliver greater value to its shareholders than would otherwise be achieved under the Managed Run-Off.

Cash and Tender Offer

The Company's cash and cash equivalents as at 29 February were £29.1 million (with cash in Euro accounts converted at ?1.1683:£1 and exclusive of the £2.5 million of cash held as collateral referred to above). Given the uncertain nature of the timing of Superbonus returns, combined with upcoming cash requirements for Unfunded Commitments (referred to above), it is important to maintain a cash buffer to ensure the Company can continue to meet its liabilities and commitments.

Accordingly, the Board proposes to return, in the coming months, no less than £17.5 million to shareholders by way of a tender offer at a fixed price of 94.28 pence per share which is the Company's last published NAV per share (the "Tender Offer"). Eligible Shareholders will each be able to elect to tender that proportion of their holding, at the time, as is represented by their entitlement under the Tender Offer, or such lower number as they wish.

The Board will publish a circular in due course, which will include further details of the Tender Offer (including the amount to be returned to shareholders in the Tender Offer and the maximum number of shares to be acquired). A General Meeting will be convened to approve the Tender Offer.

The preparation of the audited annual accounts for the year ended 31 December 2023, the implementation of the Tender Offer, the run-off of the portfolio and the continuing evaluation of any strategic proposals are now the principal objectives of the Board. The Company's portfolio currently comprises 35 private credit investments across Germany, Italy, Spain and the UK and with investment maturity periods of up to 17 years. As and when sufficient cash has been accumulated, the Board's current intention is there will be further tender offers to shareholders.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014, as it forms part of UK domestic law ("MAR"). Upon publication of this announcement, the inside information is now considered to be in the public domain for the purposes of MAR. The person responsible for arranging the release of this announcement on behalf of the Company is Apex Listed Companies Services (UK) Limited.

For further information, please contact:

Aquila Capital (Investment Adviser) Via Buchanan

Stifel Nicolaus Europe Limited (Sole Financial Adviser and Corporate Broker)

Edward Gibson-Watt, Rajpal Padam, Madison Kominski

020 7710 7600

Buchanan (Financial PR)

Charles Ryland, George Beale

020 7466 5000

Apex Listed Companies Services (UK) Limited (Company Secretary)

Sinead van Duuren

020 3327 9720

The Company's LEI is 213800AJ3TY3OJCQQC53

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NAVZQLFBZXLZBBL
12
Date   Source Headline
19th Apr 20249:55 amRNSProposed Tender Offer
6th Mar 20242:45 pmRNSUnaudited NAV and Return of Capital
19th Jan 20242:00 pmRNSUpdate re: Investment Adviser
16th Nov 202310:54 amRNSDirector Declaration
27th Sep 20237:00 amRNSHalf-year Report
25th Sep 20234:00 pmRNSHolding(s) in Company
16th Aug 20237:00 amRNSShareholder Update
11th Aug 20237:00 amRNSNet Asset Value as at 30 June 2023
14th Jun 20235:21 pmRNSResult of AGM
2nd May 20237:01 amRNSNotice of AGM
2nd May 20237:00 amRNSFinal Results
13th Apr 20231:28 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSAppointment of Sole Corporate Broker
28th Feb 20233:36 pmRNSResult of General Meeting
27th Feb 20231:24 pmRNSGeneral Meeting Update on Proxy Votes
20th Feb 20237:00 amRNSPurchase of shares in relation to inv.advisory fee
16th Feb 20237:01 amRNSDividend Declaration
16th Feb 20237:00 amRNSNAV and Fact Sheet as at 31 December 2022
13th Feb 20237:00 amRNSPublication of Circular
30th Jan 20237:00 amRNSPositive Investment Update
17th Jan 20237:00 amRNSChange of Name of Company Secretary
20th Dec 20225:32 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSTrading Update
13th Dec 20224:03 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:31 pmRNSChange of AIFM's Name
3rd Nov 20227:00 amRNSDividend Declaration
2nd Nov 202211:58 amRNSAppointment of Non-executive Director
15th Sep 20224:22 pmRNSPurchase of shares re investment advisory fees
15th Sep 20227:00 amRNSDividend Declaration
15th Sep 20227:00 amRNSHalf-year Report
12th Aug 20225:55 pmRNSHolding(s) in Company
12th Aug 20227:00 amRNSFactsheet as at 30 June 2022
12th Aug 20227:00 amRNSNet Asset Value(s)
25th Jul 20222:06 pmRNSResult of General Meeting
25th Jul 20227:00 amRNSTrading Update
29th Jun 20225:03 pmRNSDirector/PDMR Shareholding
28th Jun 20224:30 pmRNSResult of AGM
28th Jun 20224:06 pmRNSPurchase of shares re investment advisory fees
24th Jun 20227:00 amRNSAnnual Financial Report
1st Jun 20227:00 amRNSNotice of AGM
29th Apr 20227:00 amRNSAppointment of Non-executive Director
21st Apr 20227:00 amRNSResult of Investment Strategy Review
23rd Feb 20223:15 pmRNSHolding(s) in Company
17th Feb 20227:00 amRNSFactsheet as at 31 December 2021
31st Jan 20227:00 amRNSCompany Update
6th Dec 20214:55 pmRNSChange of Registered Office
21st Oct 20217:00 amRNSReduction of the share premium account
17th Sep 20216:16 pmRNSHolding(s) in Company
28th Jun 20213:23 pmRNSHolding(s) in Company
28th Jun 20213:18 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.